新闻 > 经济
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20170828/31211794.html
Server: cms-8-252
Date: 2024/11/05 19:27:47

Powered by China
China

贝达药业和美国Tyrogenex公司签约 阔步进军全球肿瘤药物市场

2017-08-28 16:31:09   中国经济网

美国东部时间8月25日上午,在美中贸易协会会长JohnFrisbie,原美国癌症中心主任SamuelBroder博士等领导和嘉宾的见证下,贝达药业股份有限公司和美国Tyrogenex公司在华盛顿正式签约,成立合资公司EquinoxSciencesLLC公司(中文名:医科诺生物科技有限公司),积极进军全球肿瘤药物市场。贝达药业董事长兼首席执行官丁列明博士和Tyrogenex公司首席执行官EricRichman代表双方公司签署战略合作协议。

贝达药业与美国Tyrogenex公司签约现场

Tyrogenex公司是一家美国生物制药企业,专注于血管内皮生长因子受体(VEGFR)和人血小板衍生生长因子受体(PDGFR)靶点的湿性年龄相关性黄斑变性和实体瘤药物的开发。Tyrogenex公司在研的X-82(Vorolanib)化合物,是一款针对血管内皮生长因子受体(VEGFR)和血小板衍化生长因子受体(PDGFR)靶点的口服抑制剂,可用于眼科及肾癌、胃癌、肺癌等多种癌症的治疗。新成立的Equinox公司,贝达药业和Tyrogenex公司各占50%的股权,共同开发Vorolanib化合物肿瘤适应症中国区域外的全球权利。对于当天的签约,SamuelBroder给予高度评价,他说,贝达药业与Tyrogenex的合作是一个了不起的决定,对贝达药业的长远发展有着重要意义,实现互利共赢、比翼齐飞。

此前,贝达药业已和Tyrogenex公司达成战略合作,以1000万美元的对价认购Tyrogenex公司新发行的G轮优先股,持有其7%的股份,主要开发Vorolanib化合物眼科适应症中国区域外的全球权利。

“这次贝达药业与Tyrogenex公司再次合作,既是强强联手又是‘亲上加亲’。”丁列明博士说,Vorolanib化合物在中国的项目名称叫CM082,由著名药物化学专家梁从新博士发明,海归博士团队创办的卡南吉医药科技(上海)有限公司,拥有其在中国区域的专利权、开发权、生产权和销售权。今年上半年,贝达药业斥资4.8亿元全面收购卡南吉,拥有CM082项目在中国区域的全部权益。

贝达药业为何对这个项目如此情有独钟?贝达药业资深副总裁兼首席医学官谭芬来博士透露了其中的奥秘。他说,Vorolanib(CM082)是针对VEGFR、PDGFR、c-Kit、Flt-3和CSF1R等多靶点的小分子靶向新药,临床剂型为口服片剂,不但具有针对VEGFR和PDGFR抗血管生成等多靶点的显著疗效,同时克服了这一类靶向药常见的高毒副作用,并且一改同类药物需要进行注射的弊端,未来在眼科、肾癌等领域疾病的治疗中前景广阔。

上一页1/2下一页
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20170828/31211794.html
Server: cms-8-252
Date: 2024/11/05 19:27:47

Powered by China
China
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20170828/31211794.html
Server: cms-8-252
Date: 2024/11/05 19:27:47

Powered by China
China

相关阅读

404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20170828/31211794.html
Server: cms-8-252
Date: 2024/11/05 19:27:47

Powered by China
China
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20170828/31211794.html
Server: cms-8-252
Date: 2024/11/05 19:27:47

Powered by China
China
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20170828/31211794.html
Server: cms-8-252
Date: 2024/11/05 19:27:47

Powered by China
China
分享到:
0 0
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20170828/31211794.html
Server: cms-8-252
Date: 2024/11/05 19:27:47

Powered by China
China
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20170828/31211794.html
Server: cms-8-252
Date: 2024/11/05 19:27:47

Powered by China
China

美图推荐

404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20170828/31211794.html
Server: cms-8-252
Date: 2024/11/05 19:27:47

Powered by China
China
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20170828/31211794.html
Server: cms-8-252
Date: 2024/11/05 19:27:47

Powered by China
China
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20170828/31211794.html
Server: cms-8-252
Date: 2024/11/05 19:27:47

Powered by China
China
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20170828/31211794.html
Server: cms-8-252
Date: 2024/11/05 19:27:47

Powered by China
China

为您推荐

加载更多>>
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20170828/31211794.html
Server: cms-8-252
Date: 2024/11/05 19:27:47

Powered by China
China
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20170828/31211794.html
Server: cms-8-252
Date: 2024/11/05 19:27:47

Powered by China
China
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20170828/31211794.html
Server: cms-8-252
Date: 2024/11/05 19:27:47

Powered by China
China